SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Strategies & Market Trends : Pluvia's Fist.com - Pluvia's Plays & Portfolio

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Pluvia who wrote (1382)3/1/2001 10:46:52 PM
From: Pluvia  Read Replies (1) of 1766
 
This post is for Wallstblus & Bhobbit on the NPRO yahoo board.

We are long NPRO, we like the stock and continue to accumulate on dips.

We believe while the timing is unknown, the result is fairly certain... That being NPRO has everything in place to be a major player in the Paclitaxel biz - a 1.7 billion dollar US market last year.

With what appears to be a strong IP position, the raw material to produce Paclitaxel, (5+ million yew trees), manufacturing, US distribution via their partner Abbott and litigation protection via an agreement with Abbott who foots the bill, we believe the future of NPRO is very bright.


Cheers

~p
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext